How long does it take to feel Wegovy working — and what should you notice first?

Step 1: The first injection and early weeks (weeks 1–4)

The first Wegovy pen contains the 0.25 mg dose. This isn't a therapeutic dose in the sense of driving significant weight loss; its job is to let your system adjust to the medicine before the dose climbs. Even so, a lot of people are surprised by what they notice fairly quickly.

Within the first few days, the most common experience is a subtle shift in appetite, meals feel satisfying with less food, or the urge to snack between meals softens. Some people describe it as the background noise of hunger turning down. That's semaglutide slowing gastric emptying and acting on appetite-regulating pathways in the brain, as described in the NHS semaglutide medicines guide.

Nausea is also common in these first weeks, particularly in the 24 to 48 hours after an injection. It's worth keeping your pen in the fridge door where you'll see it, and planning your injection day so you're not eating a large meal immediately afterwards. The nausea usually eases within a few days. Constipation, burping and a feeling of fullness are also reported. None of these mean the medicine isn't working, they're signs it's active.

Weight on the scale may not shift dramatically yet, and that's expected. If you're wondering how long it takes to get Wegovy, including how quickly a prescription can be processed and your pens dispatched, that guide covers the full journey from consultation to delivery. The groundwork is being laid.

Step 2: Dose increases and when results become visible (weeks 5–20)

Wegovy is titrated in roughly four-weekly steps: 0.25 mg, then 0.5 mg, then 1.0 mg, then 1.7 mg, then 2.4 mg, the standard maintenance dose. Your prescriber guides this schedule. Each step up can bring a brief return of early side effects before your body resettles.

By weeks four to eight, most people are seeing the scale move with some consistency. Clothes feel different before the numbers feel dramatic. Energy levels can fluctuate, some people feel lighter and more mobile; others notice fatigue, particularly around dose changes. Both are normal.

The appetite suppression tends to deepen as the dose increases. By the time patients reach 1.0 mg or 1.7 mg, many describe genuinely forgetting to eat in a way that felt impossible before. Portion sizes shrink without effort. That's where the real mechanism kicks in for most people.

If you're tracking progress and feel things are moving slowly, it helps to know that the STEP 1 trial (the pivotal semaglutide 2.4 mg study published in the New England Journal of Medicine) ran for 68 weeks. The largest losses accumulated in the second and third quarters of that period, not the first month.

Step 3: Maintenance and longer-term weight loss (months 4–12 and beyond)

Once someone reaches 2.4 mg and has been on it for a full titration cycle, weight loss often continues steadily for several more months. The STEP 1 trial reported an average reduction of around 15% of body weight over 68 weeks at 2.4 mg. That average includes people who lost more and people who lost less, individual results differ meaningfully.

The full weight-loss timeline on Wegovy is not linear. There are often periods where the scale barely moves for a week or two, followed by a shift. These plateaus are normal and don't indicate the medicine has stopped working. Consistency with the injection schedule and with eating habits matters throughout.

NICE's recommendation for semaglutide (TA875) includes a checkpoint: if less than 5% weight loss has occurred after six months at the maintenance dose, continuing treatment should be reviewed. For most people who tolerate the medicine well and reach full dose, six months brings much more than 5%. But this is why clinical oversight across the treatment period matters, not just at the start. You can read a plain-English breakdown of the feeling timeline if you're trying to judge where you are.

What if you're not feeling any effect yet?

A small number of people reach the first dose increase and feel very little, no nausea, no appetite change, nothing obvious. This doesn't necessarily mean the medicine isn't working biologically, but it's worth noting and raising with your prescriber before the next dose step. Occasionally the absence of any GI response at all is a sign worth exploring.

It's also worth being honest about whether lifestyle changes are running alongside treatment. Wegovy works alongside a reduced-calorie diet and increased activity, not instead of them. The weight-loss response is shaped by both.

If side effects feel unmanageable at any point, contact your prescriber before adjusting anything yourself. Slowing titration is sometimes the right call. Our support team is available seven days a week if you need to reach us outside of a scheduled review.

Wondering about the cost context for private treatment? A plain guide to Wegovy pricing explains what a legitimate private prescription includes. When you're ready to talk through whether Wegovy is suitable for you, speak to our prescribers, consultations are free and reviewed the same day by a GPhC-registered clinician.